The Mayak Worker Dosimetry System-2013 (MWDS-2013 uses a model developed by Leggett and colleagues to represent the biokinetic behaviour of plutonium after uptake to blood. Of particular importance, with regard to estimating intakes (and doses), is the distribution of activity between urine and body organs (particularly liver and skeleton). In this study, measurement data (urine and autopsy) from around 500 Mayak workers have been used to validate use of this model. A robust method has been developed and used to estimate intakes from both urine and autopsy data separately, and the ratio of these estimates has been calculated for each worker. The geometric mean ratio has been shown to lie within a range of 0.92-1.14, depending on assumptions made. Since this range includes 1, the hypothesis that the model is unbiased with regard to estimating intakes either with urine or autopsy data cannot be rejected on the basis of these data. This lends weight to the argument for increasing the MWDS-2013 cohort to include an additional 500 workers for whom only autopsy data are available, and who have previously been excluded from the cohort. Future directions in which this work could be extended are also suggested.
INTRODUCTION
In order to estimate intakes of plutonium from bioassay measurements such as urine samples, and to calculate organ doses, it is necessary to have a realistic representation of the biokinetic behaviour of plutonium following entry into the body. Such biokinetic models are usually separated into (1) a respiratory tract model, which describes the biokinetics in the lungs and extrathoracic regions and also the rates of absorption to blood and clearance to the alimentary tract; (2) an alimentary tract model, which describes the clearance of ingested activity through to excretion in faeces and also the absorption to blood and (3) a systemic model, which describes the biokinetic behaviour of dissolved activity reaching the blood. It is the systemic model, which is the subject of this paper.
The current systemic model, recommended by the International Commission on Radiological Protection (ICRP) for radiological protection purposes, is defined in ICRP Publication 67 (1) . This model describes how plutonium reaching the blood accumulates in the liver and skeleton, and also the rate of excretion to urine. The accuracy of this model in predicting these quantities could in theory be tested by making measurements of a worker's urinary excretion rates, followed by measurements of the subsequent skeletal and liver burdens at death. Both the urine and autopsy measurements, together with the systemic model, will provide estimates of the worker's intake. Indications of a discrepancy between these estimates of intake based on urine and autopsy measurements have been reported previously for plutonium workers at the Sellafield site in Cumbria, UK (2, 3) . ICRP is currently in the process of reviewing all of its biokinetic models (4) to ensure that they make use of the latest scientific data. For plutonium, they are planning to use a revised systemic model developed by Leggett et al. (5) . However, since the ratio of urinary excretion to liver and skeleton burdens is similar between the two models (current and revised), any conclusions reached previously on discrepancies between estimates of intake based on autopsy and urine data are likely to also apply to the revised systemic model.
In the Mayak Worker Dosimetry System (MWDS-2013), it is planned to adopt the new model proposed by Leggett et al. (5) , and the aim of this paper is to validate its use. Although the new model was initially developed from data collated on Mayak workers, there have been many improvements over the last 10 years in the methodology used to generate the measurement data from the raw measurements:
• an improved algorithm used to derive skeletal burdens from sample measurements (6) ;
• an improved algorithm used to derive lung burden estimates from measurements of lung tissue samples (7) and • new volumetric scaling factors used to derive 24 h urinary excretion rates from the actual urine samples (8) ;
and also in the various models and assumptions used to interpret the data:
• changes in the respiratory tract model (9) ; • the absorption rates of plutonium materials (10) and • assumptions about the exposure scenarios (11) .
In view of these new developments, it is necessary to validate the revised model using these latest methodologies.
At the Mayak Production Association plant, there are around 500 workers for whom both urine measurements and autopsy data exist, and the aim of this paper is to use these data to test the adequacy of the new Leggett model adopted in MWDS-2013.
Previous attempts to reconcile Mayak organ doses based on autopsy and urine measurements have been carried out by Southern Urals Biophysical Institute (SUBI) staff, and this has resulted in different conclusions, depending on which analysis method was used. Methods based on regression analysis between organ dose estimates derived from autopsy and urine tended to show a bias, while those based on ratios of estimates tended to show no bias. In this paper, a new method is developed, which is robust to the assumptions of many model parameters.
METHODOLOGY
Previous analyses carried out by SUBI researchers have focused on comparing various organ doses estimated using both autopsy and urine data. This analysis differs from previous work in several respects. First, the autopsy data on which the analysis is based are derived using more up-to-data algorithms to calculate organ content at time of death from measurements made on organ samples (6, 7) , and also to calculate estimates of the true 24 h urinary excretion rate from measured urine samples (8) . Second, the assumed biokinetic behaviour of plutonium is modelled using more realistic models (9) . Third, the proposed methodology is more robust with regard to bias between estimates based on urine and autopsy data.
Initially, 10 Mayak workers, who were exposed to airborne plutonium and for whom there were both urine and autopsy data available, were randomly selected. In all cases, the measurements consisted of measurements of activity of plutonium in:
• lung content (excluding lymph nodes);
• lymph node content;
• liver content;
• skeleton content and • multiple urine samples taken at different times during the work history.
In this analysis, the activity in lungs and lymph was ignored. To include these data would require additional assumptions about the rate of transfer from lungs to lymph (highly uncertain). Also, it can be shown that the partitioning of activity between body organs and urine is insensitive to the rate of uptake to blood, i.e. the plutonium is partitioned between urine and organs very quickly after uptake, whenever that uptake occurs. Also, it is known that for any individual the total fractions going to liver or skeleton can be quite variable, but since these fractions are inversely correlated, the total uptake to (liver + skeleton) is much less variable. Also, since the total uptake by (liver + skeleton) is around 90%, there is relatively little room for variation. Therefore, in this analysis, the liver and skeletal burdens were added together and used as a single robust measure of systemically retained plutonium. This (liver + skeleton) measurement was then used in conjunction with the Leggett model, and other biokinetic models of the lungs and GI tract, and assumptions about the intake scenario to derive a single estimate of the intake (Bq) for each worker.
To derive a corresponding estimate of intake based on the urine data required fitting the model to all of the urine measurements simultaneously. This latter estimate will in turn depend on the assumed uncertainties in the urine data. For this analysis, it was assumed that each urine measurement was lognormally distributed around a true value with a geometric standard deviation (σ g ) of 1.8. Although the uncertainty is not well known, it can be shown that this estimate is independent of the actual value of σ g . Since urine samples were taken and measured under similar conditions, it seems reasonable to assume that whatever the value of σ g , it would be similar for all measurements. This also enables a unique (maximum likelihood) estimate of the intake to be derived.
Finally, it was assumed for simplicity that the intake regime was either a simple constant chronic intake throughout the period of employment or a one-time acute intake. A single ratio of the estimate of intake based on the autopsy measurement to that based on the urine data can now be derived for each of these extremes. A value of 1 would suggest that the Leggett model correctly partitions activity between (liver + skeleton) and urine, while significant deviations from 1 would indicate problems with the model.
A sensitivity analysis of the ratio (urine/autopsy) showed that it was insensitive to assumptions about the intake regime, and also to assumptions about the rate of absorption from lungs to blood.
The preliminary results for 10 Mayak workers is shown in Table 1 .
VALIDATION LEGGETT MODEL
The geometric mean of the 10 ratios is 0.9. The intake estimates are also plotted in Figure 1 .
A regression line on the logs of the quantities (consistent with the assumption of a log-normally distributed uncertainty) gives a gradient of 0.9, which is consistent with the geometric mean of the individual ratios.
These initial results indicate that there is good agreement between estimates of intake based on autopsy and urine, which in turn indicates that the Leggett model performs well, at least with these 10 workers. In order to further validate the model, it is necessary to extend the analysis to include more workers.
EXTENDING THE ANALYSIS
The estimates of intake based on autopsy and urine measurements were calculated individually using the software IMBA Professional Plus (12) . Although the calculations were not CPU intensive, they were labour intensive since each case had to be analysed individually. In order to analyse the entire cohort of 507 cases, it was necessary to automate the system of calculation. Also, because of the abundance of data the researchers were able to exclude data, which may have been problematic, without seriously affecting the statistical power of the analysis.
Automation of the analysis
Automation of the system was a two-stage process involving co-operation between SUBI (Russia) and Public Health England (PHE, UK). At PHE, the software IMBA was extended to enable it to run in batch mode, i.e. to run sequentially through data sets and store the intakes based on autopsy and urine in a common file. At SUBI, code was developed to create data sets in a form that was suitable for input directly into the IMBA code. Once the development had been completed and quality assured, the entire cohort could be analysed in a few minutes.
Pre-selection of the measurement data
The complete cohort, which contained only those cases where both urine and autopsy measurement data existed, comprised 507 cases. Of these, 25 had already been excluded by SUBI for previous analyses. These exclusions included cases where:
• the total skeleton + liver burden was <60% of the total systemic activity. This is indicative of a non-standard behaviour possibly as a result of illness (eight cases); • cases with very low body burdens, on the verge of what can be reliably measured (three cases) and • cases where there were no lymph data (14 cases).
Technically, the 14 cases with no lymph data could be used for this analysis, since no use is made of lung or lymph data. This will be reconsidered in any further analyses. This reduced the cohort to 482. Next, it was decided to exclude all cases where the urine measurements were recorded as less than the decision threshold (65 cases). Although the software used (IMBA Professional Plus) deals with such data, a maximum likelihood estimation of intake requires at least one positive measurement. This reduced cohort of 417 was then used in our analysis.
The extended analysis
Estimates of intake based on urine data only (u i ) and autopsy data only (a i ) were then calculated using the assumptions described earlier, and 417 ratios (r i = u i /a i ) were calculated. To investigate the effect of the assumed intake regime, the analysis was performed twice: once assuming a single acute intake at the beginning of the employment history and the other assuming a constant chronic intake throughout the work history. Box plots were constructed to identify possible outliers. Two outliers were identified for the chronic intake results and three were identified for the acute intake results. These were excluded from the analysis. The mean, standard deviation and standard error of the logs of the ratios were calculated. The anti-logs of these quantities correspond to the geometric mean, the geometric standard deviation and the geometric standard error.
RESULTS AND DISCUSSION
The results are shown in Table 2 for both the acute and chronic intake assumptions. Figure 2 shows the estimates of intake based on urine and autopsy for the acute intake assumption.
Visual inspection (Figure 2 ) of the estimates of intake based on urine and autopsy shows a good agreement. Individual ratios of urine/autopsy estimates have been calculated under two different assumptions: the first is that the intake was an acute intake at the beginning of the work history and the second is that the intake was constant throughout the work history. Since intakes are likely to have been higher in the past, these two assumptions can be regarded as extremes, with the true ratio lying somewhere in between. Table 2 thus shows that the geometric means of the ratios of intake estimates from urine to autopsy lie somewhere between 0.92 and 1.14. Therefore, a value of 1 for the ratio cannot be ruled out on statistical grounds.
The very small standard error (1.04) of the geometric mean estimate shows how sensitive this technique is, although implicit in this value is the assumption that there are no other major sources of uncertainty or bias. It is clear that the methodology used is capable of detecting small biases, and there are a number of areas in which this method could thus be usefully extended. For example:
• repeating the analysis with the subjects' actual work history; • grouping the data according to some health status of the workers; • grouping the data according to whether exposure was to oxides, nitrates or both; • calculating the ratios in different intake groups (low, medium, high); • investigating the sensitivity of the ratios to different volumetric scaling factors of the urine or • looking at the effect of including urine data recorded as less than the decision threshold.
It is important to realise that this study does not prove that the Leggett model is completely accurate for describing the biokinetic behaviour of plutonium after uptake to blood. There may well be other measurements from other sources that could contradict other model predictions. However, what can be concluded is that as far as the model predicts partitioning between urine and the two major body organs (liver + skeleton), the very sensitive methods employed here serve to validate the Leggett model.
CONCLUSION
Measurement data, consisting of urine measurements and autopsy data, on around 400 Mayak workers have been used to validate the systemic Figure 2 . Estimates of intake based on urine and autopsy (liver + skeleton) measurements for 414 Mayak workers. model used in MWDS-2013. A robust methodology, which is very sensitive to bias in estimates of intake based on urine or autopsy data, has been developed and used on the Mayak data. The results show that the model accurately describes the partitioning between urine and total amount going to liver + skeleton. This conclusion lends weight to the argument for extending the MWDS-2013 cohort in the future to include 500 cases where only autopsy data (no urine data) are available. This study also points out a number of areas where the work could be extended.
